Topic Review
Asymmetric Dimethylarginines
Asymmetric dimethylarginine (ADMA) is the most potent endogenous inhibitor of nitric oxide synthase (NOS), with higher levels in patients with end-stage renal disease (ESRD). ADMA has shown to be a significant predictor of cardiovascular outcome and mortality among dialysis patients. 
  • 354
  • 21 Jan 2022
Topic Review
Asymptomatic Stroke in Percutaneous Non-Coronary Intervention Procedures
Advancements in clinical management, pharmacological therapy and interventional procedures have strongly improved the survival rate for cardiovascular diseases (CVDs). Nevertheless, the patients affected by CVDs are more often elderly and present several comorbidities such as atrial fibrillation, valvular heart disease, heart failure, and chronic coronary syndrome. Standard treatments are frequently not available for “frail patients”, in particular due to high surgical risk or drug interaction. In the past decades, novel less-invasive procedures such as transcatheter aortic valve implantation (TAVI), MitraClip or left atrial appendage occlusion have been proposed to treat CVD patients who are not candidates for standard procedures. These procedures have been confirmed to be effective and safe compared to conventional surgery, and symptomatic thromboembolic stroke represents a rare complication. However, while the peri-procedural risk of symptomatic stroke is low, several studies highlight the presence of a high number of silent ischemic brain lesions occurring mainly in areas with a low clinical impact. The silent brain damage could cause neuropsychological deficits or worse, a preexisting dementia, suggesting the need to systematically evaluate the impact of these procedures on neurological function. 
  • 299
  • 18 Jan 2022
Topic Review
Asynchronous Environment Assessment
The emergence and global spread of COVID-19 has disrupted the traditional mechanisms of education throughout the world. Institutions of learning were caught unprepared and this jeopardised the face-to-face method of curriculum delivery and assessment. Teaching institutions have shifted to an asynchronous mode whilst attempting to preserve the principles of integrity, equity, inclusiveness, fairness, ethics, and safety. A framework of assessment that enables educators to utilise appropriate methods in measuring a student’s progress is crucial for the success of teaching and learning, especially in health education that demands high standards and comprises consistent scientific content. 
  • 2.0K
  • 30 Sep 2021
Topic Review
AT1/AT2 Receptor Equilibrium in the Renin Angiotensin System
The AT1 receptor has mainly been associated with the pathological effects of the renin-angiotensin system (RAS) (e.g., hypertension, heart and kidney diseases), and constitutes a major therapeutic target. In contrast, the AT2 receptor is presented as the protective arm of this RAS, and its targeting via specific agonists is mainly used to counteract the effects of the AT1 receptor. The discovery of a local RAS has highlighted the importance of the balance between AT1/AT2 receptors at the tissue level. Disruption of this balance is suggested to be detrimental. The fine tuning of this balance is not limited to the regulation of the level of expression of these two receptors. Other mechanisms still largely unexplored, such as S-nitrosation of the AT1 receptor, homo- and heterodimerization, and the use of AT1 receptor-biased agonists, may significantly contribute to and/or interfere with the settings of this AT1/AT2 equilibrium.
  • 195
  • 30 Aug 2023
Topic Review
AT1 Receptor in Cerebrovascular Diseases
Ang II is known as the main effector of the RAS. Ang II binds with a similar affinity to two receptors: the Ang II type 1 receptor (AT1) and type 2 receptor (AT2), both belonging to the G protein-coupled receptor (GPCR) family and sharing 50% homology and 34% identity in their amino acid sequence. Ang II activation of AT1 is acknowledged as triggering most of the known effects of RAS stimulation, such as vasoconstriction, water and sodium retention and aldosterone release by the adrenal glands. This leads to increases in blood pressure, cardiovascular remodeling and fibrosis. Due to its wide physiological effects, AT1 plays a critical role in many pathological conditions and cardiovascular diseases, like cardiac hypertrophy, hypertension and heart failure.
  • 528
  • 05 Jul 2021
Topic Review
Ataxia in Neurometabolic Disorders
Ataxia is a movement disorder that manifests during the execution of purposeful movements. It results from damage to the structures of the cerebellum and its connections or the posterior cords of the spinal cord. It should be noted that, in addition to occurring as part of many diseases, pediatric ataxia is a common symptom in neurometabolic diseases. 
  • 402
  • 11 Jan 2023
Topic Review
Ataxia Telangiectasia Mutated (ATM) Control
Control of excessive oxidative stress is vital within cells to maintain cellular and genome integrity. Damage to the genome is particularly detrimental to host organisms and cells have evolved complex pathways to detect and coordinate response to and repair of DNA damage. But even with successful DNA damage repair, activation of the DNA damage response (DDR) can modulate inflammatory responses directly and through epigenetic mechanisms. Studies indicate that many pathophysiological states that are characterized by elevated oxidative stress are also associated with upregulation of the DNA damage response (DDR).
  • 560
  • 22 Sep 2021
Topic Review
Atherogenic Dyslipidemia Associated with Metabolic Syndrome
Atherogenic dyslipidemia plays a critical role in the development of metabolic syndrome (MetS), being one of its major components, along with central obesity, insulin resistance, and hypertension.
  • 788
  • 19 Jul 2023
Topic Review
Atherosclerosis in Prediabetes
Atherosclerosis is a chronic inflammatory process within the arterial wall.
  • 404
  • 29 Apr 2021
Topic Review
Atherosclerosis, Diabetes Mellitus, and Cancer
The involvement of cardiovascular disease in cancer onset and development represents a contemporary interest in basic science. It has been recognized, from the most recent research, that metabolic syndrome-related conditions, ranging from atherosclerosis to diabetes, elicit many pathways regulating lipid metabolism and lipid signaling that are also linked to the same framework of multiple potential mechanisms for inducing cancer.
  • 419
  • 26 Jul 2023
  • Page
  • of
  • 1352
ScholarVision Creations